Home>US Stocks>Seattle Genetics, Inc.
shareSHARE

SGEN

Seattle Genetics, Inc.

$159.06
+ $2.85 (1.82%) 1D

Performance

Today’s Low
NA
    Today’s High
    NA
    52W Low
    NA
      52W High
      NA
      Open PricePrev. CloseVolumeAvg. Volume
      $0.00$0.00NANA

      Fundamentals

      Market Cap$28.94 B
      P/B Ratio8.5
      P/E Ratio48.5
      Enterprise Value$28.59 B
      Div. Yield0.00%
      Book Value18.67
      EPS(TTM)-0.47
      ROENA
      Understand Fundamentals
      info

      About the Company

      Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company markets ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgki
      Organisation
      Seattle Genetics, Inc.
      Industry
      Biotechnology
      Headquarters
      Bothell, WA
      ⓒ 2016-2021 Groww. All rights reserved, Built with in India
      MOST POPULAR ON GROWWVERSION - 1.8.8
      STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
      MUTUAL FUNDS COMPANIES: ICICI PRUDENTIAL  | HDFC  | NIPPON INDIA  | ADITYA BIRLA SUN LIFE  | SBI  | UTI  | FRANKLIN TEMPLETON  | KOTAK MAHINDRA  | IDFC  | DSP  | AXIS  | TATA  | L&T  | SUNDARAM  | PGIM  | INVESCO  | LIC  | JM FINANCIAL  | BARODA PIONEER  | CANARA ROBECO  | HSBC  | IDBI  | INDIABULLS  | MOTILAL OSWAL  | BNP PARIBAS  | MIRAE ASSET  | PRINCIPAL  | BOI AXA  | UNION KBC  | TAURUS  | EDELWEISS  | NAVI  | MAHINDRA  | QUANTUM  | PPFAS  | IIFL  | Quant  | SHRIRAM  | SAHARA | ITI
      ABOUT GROWW
      keyboard_arrow_down